RARE DISEASES A–Z · LETTER C

Castleman Disease

Castleman disease is a rare disorder of the lymph nodes, which become enlarged and overactive. It is not a cancer, though it is usually diagnosed and treated by blood specialists because it can behave seriously. The key question in every case is how widespread it is, because that decides both the outlook and the treatment.

By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026

Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.

In short: Castleman disease is lymph node overgrowth with inflammation. Unicentric disease (one node group) is usually cured by surgery. Multicentric disease (widespread) is driven by inflammatory signals and treated with immune-targeted therapy.

The guide

The basics

The dividing line is how many node regions are involved. Unicentric disease affects one group of nodes, often in the chest or abdomen; it may cause pressure symptoms or be found by chance on a scan, and general symptoms are often absent. Multicentric disease involves nodes throughout the body and is driven by inflammatory signals — especially interleukin-6 (IL-6) — producing fevers, drenching night sweats, weight loss, profound fatigue, fluid accumulation, enlarged liver and spleen, and anaemia. Some multicentric cases are driven by the HHV-8 virus, particularly in people with weakened immunity; others are idiopathic, with no cause found. A severe form can flare into a life-threatening inflammatory storm affecting several organs at once.

How it works

Diagnosis starts with a lymph node biopsy — ideally removing a whole node — showing the characteristic Castleman pattern under the microscope. Because lymphoma and infections can look similar clinically, the biopsy also excludes them. Blood tests typically show high inflammation markers, anaemia, abnormal proteins, and very high IL-6 activity in active multicentric disease. Testing for HHV-8 and HIV is essential, since HHV-8-associated disease is treated differently. Scans (usually CT or PET-CT) map how widespread the nodes are, which settles the unicentric-versus-multicentric question. Specialist criteria then classify idiopathic multicentric disease and grade its severity, because treatment intensity follows severity.

Day to day

Unicentric disease is usually cured by surgically removing the affected node group; when surgery is not possible, radiotherapy or medicines that shrink and quieten the node are alternatives. Multicentric disease is treated by switching off the inflammatory drive: the anchor therapy is an antibody that blocks IL-6 or its receptor, given by infusion or injection, which controls symptoms and blood abnormalities in many people with the idiopathic form. Steroids calm severe flares, and for HHV-8-associated disease an antibody that removes B cells (the virus's host cells) is central, alongside treating any HIV. Resistant cases may need chemotherapy-style combinations. Treatment is often long-term, and response is tracked with symptoms, blood tests, and scans.

When to get help

After treatment, follow-up watches blood counts, inflammation markers, kidney function, and symptoms, because multicentric disease can relapse after long quiet periods. Keep vaccinations reviewed with your team, and report fevers, new lumps, swelling, or returning night sweats early rather than waiting for a scheduled visit. If your disease is HHV-8-associated and you have HIV, keeping HIV fully treated is part of Castleman care. Seek urgent help for high fever with breathlessness, confusion, or rapidly increasing swelling — the flare syndrome of severe multicentric disease can escalate quickly and responds best to early treatment.

See a doctor promptly if: High fever with breathlessness, confusion, or rapidly increasing body swelling in multicentric Castleman disease can signal a severe flare — seek emergency care.

Common questions

Who was Castleman?

It is named after Dr Benjamin Castleman, the pathologist who described the characteristic lymph node changes in the 1950s. The name describes the microscope pattern — sorting out which type a person has requires much more than the biopsy alone.

Is Castleman disease a cancer?

No. The lymph nodes are overgrown and inflamed, not cancerous, and Castleman disease does not spread like a cancer. However, people with multicentric disease have an increased risk of lymphoma over time, which is one reason long-term follow-up continues even in remission.

Is a virus involved?

In some people, yes: HHV-8 — a herpes-family virus, the same one linked to Kaposi sarcoma — drives the disease, particularly in people with weakened immunity such as untreated HIV. But many multicentric cases have no virus found; those are called idiopathic, and their driver is still being researched.

Can Castleman disease be cured?

Often, yes, for unicentric disease — removing the single enlarged node group usually ends the problem completely, and most people need no further treatment beyond follow-up. Multicentric disease is managed rather than cured, though long remissions are common with modern therapy.

More in Letter C

Related

Sources

This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Castleman disease treatment depends entirely on subtype; decisions belong with your haematology team.